Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Anti-HIV Drugs Slash Risk of Virus Transmission by 92 Percent

June 1, 2010

A newly published study's results provide perhaps the strongest evidence to date that the drugs used to treat HIV also prevent its spread. In a trial involving heterosexual couples where one partner was HIV-infected and the other was not, AIDS drugs reduced the risk of viral transmission to the uninfected partner by 92 percent.

In seven African countries, the researchers recruited 3,381 serodiscordant heterosexual couples. During the study, 349 people initiated antiretroviral therapy (ART) at a median CD4 cell count of 198. The other infected participants received a placebo. An ethics committee closely monitored the trial, whose components included a safe-sex training course and routine health checkups. Every three months, the uninfected partners were tested for HIV.

Advertisement

At 24 months, 103 partners who had been HIV-free at baseline had been infected by their partner. Genetic testing was used to confirm whether an infection had originated with the patient's partner or with someone outside the trial. Only one of the 103 genetically linked infections was transmitted by a partner on ART.

The scientists noted that ART may lower -- but does not eliminate -- the risk of transmission, so safe-sex counseling must remain a part of prevention efforts for serodiscordant couples.

"Low CD4 cell counts and high plasma HIV-1 concentrations might guide use of ART to achieve an HIV-1 prevention benefit," the authors concluded. "Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission."

The full report, "Heterosexual HIV-1 Transmission After Initiation of Antiretroviral Therapy: A Prospective Cohort Analysis," was published in The Lancet (2010; doi:10.1016/S0140-6736(10)60705-2).

Back to other news for June 2010

Adapted from:
Agence France Presse
05.26.2010


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More Research on Mixed-Status Couples

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement